Veracyte Reports Strong Q2 Growth with 27% Revenue Increase
Veracyte's Q2 revenue surged 27% to $114.4M, fueled by strong demand for genomic tests. Full-year guidance raised to $432M-$438M.
- Latest
- Trending
Veracyte's Q2 revenue surged 27% to $114.4M, fueled by strong demand for genomic tests. Full-year guidance raised to $432M-$438M.
Sempra missed Q2 profit and revenue estimates due to California segment's decline, while Texas unit shows potential growth.
"Logitech’s new MX Ink stylus, designed for Meta Quest, hints at what Apple Vision Pro users might desire for enhanced ...
Kenya's President Ruto withdraws a controversial finance bill amid deadly protests over proposed tax hikes and rising costs of necessities.
Volkswagen will invest up to $5B in Rivian to develop advanced EV technology, aiming to launch new vehicles by the ...
"Microsoft's Gen-AI investments yield high capital efficiency, with AI revenue growth surpassing early Azure benchmarks, per Goldman Sachs."
Studio369 launches Ethereum token with MetalCore's Closed Beta 3, introducing new gameplay modes, economic features, and NFT in-game assets.
GAO report criticizes DoE’s tech licensing oversight, citing risks of foreign acquisition & urging better evaluation and risk management policies.
Eurofins Scientific stock plunges by 20% amid Muddy Waters' short-seller allegations of complex corporate structure and questionable practices.
"Revolutionize data storage with the Stellar 256TB SSD Array: unmatched capacity, performance, and reliability for enterprises and professionals."
We are building the future together with you. We write content with maximum speed and excellent quality. Each material is accompanied by an analyst's commentary.